CD
Therapeutic Areas
Regeneration Biomedical Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Autologous Wnt-activated ADSC Therapy | Alzheimer's Disease | Phase 1 |
Leadership Team at Regeneration Biomedical
BM
Bill Miller
CEO
BL
Bob Lynn
COO/Research Director
HS
Hans S. Keirstead, PhD
Scientific Advisor
GN
Gabriel Nistor, MD
Scientific Advisor
YJ
Yasir Jassam, MBChB MRCP(UK) FRCP(Glasg) FRCP FAAN
Scientific Advisor
MS
Monica Siegenthaler Meacham, PhD
Regulatory Director